{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:51:22Z","timestamp":1793339482237,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":69,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmet.2026.06.012","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:32:04Z","timestamp":1783438324000},"page":"1540-1556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-3324","authenticated-orcid":false,"given":"Marc","family":"Prentki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-3819","authenticated-orcid":false,"given":"Christopher J.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Thorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"Corkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3143-5045","authenticated-orcid":false,"given":"Marc Y.","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2026.06.012_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2017.03.048","article-title":"Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial","volume":"241","author":"Damluji","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cmet.2026.06.012_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cmet.2026.06.012_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400082","article-title":"A patient-level meta-analysis of intensive glucose control in critically ill adults","volume":"3","author":"Adigbli","year":"2024","journal-title":"NEJM Evid."},{"key":"10.1016\/j.cmet.2026.06.012_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMoa1612348","article-title":"Tight glycemic control in critically ill children","volume":"376","author":"Agus","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib9","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/M23-1490","article-title":"Newer pharmacologic treatments in adults with type 2 diabetes: a systematic review and network meta-analysis for the American College of Physicians","volume":"177","author":"Drake","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(13)70027-5","article-title":"Intensive insulin for type 2 diabetes: the risk of causing harm","volume":"1","author":"Nolan","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.012_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0893-133X(99)00129-3","article-title":"Allostasis and allostatic load: implications for neuropsychopharmacology","volume":"22","author":"McEwen","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cmet.2026.06.012_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1479164119827611","article-title":"Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift","volume":"16","author":"Nolan","year":"2019","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.cmet.2026.06.012_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13679-017-0261-z","article-title":"Hyperinsulinemia: a cause of obesity?","volume":"6","author":"Erion","year":"2017","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.cmet.2026.06.012_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/db11-1483","article-title":"Banting lecture 2011: hyperinsulinemia: cause or consequence?","volume":"61","author":"Corkey","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1152\/physrev.00029.2024","article-title":"The flux of energy in critical illness and the obesity paradox","volume":"105","author":"Jaitovich","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cmet.2026.06.012_bib19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2337\/dc24-2459","article-title":"Persistent hyperglycemia and insulin resistance with the risk of worsening cardiac damage in adolescents: a 7-year longitudinal study of the ALSPAC Birth Cohort","volume":"48","author":"Agbaje","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2026.06.012_bib22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0026-0495(78)80006-7","article-title":"Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology","volume":"27","author":"Jeanrenaud","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/j.cmet.2026.06.012_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00281984","article-title":"An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause","volume":"28","author":"Jeanrenaud","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","article-title":"Defining the underlying defect in insulin action in type 2 diabetes","volume":"64","author":"Batista","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib25","doi-asserted-by":"crossref","first-page":"17787","DOI":"10.1073\/pnas.0902380106","article-title":"Insulin resistance is a cellular antioxidant defense mechanism","volume":"106","author":"Hoehn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.012_bib26","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","article-title":"Phosphorylation of IRS proteins, insulin action, and insulin resistance","volume":"296","author":"Boura-Halfon","year":"2009","journal-title":"Am. J. Physiol., Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib27","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/db13-0246","article-title":"Direct autocrine action of insulin on beta-cells: does it make physiological sense?","volume":"62","author":"Rhodes","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C","article-title":"Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years","volume":"14","author":"Randle","year":"1998","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.cmet.2026.06.012_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"Reaven","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cmet.2026.06.012_bib30","first-page":"353","article-title":"Diabetes mellitus: a \"thrifty\" genotype rendered detrimental by \"progress\"?","volume":"14","author":"Neel","year":"1962","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cmet.2026.06.012_bib31","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1152\/ajpendo.90945.2008","article-title":"Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation","volume":"297","author":"Hoy","year":"2009","journal-title":"Am. J. Physiol., Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib32","doi-asserted-by":"crossref","first-page":"E1358","DOI":"10.1152\/ajpendo.00133.2007","article-title":"Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation","volume":"293","author":"Hoy","year":"2007","journal-title":"Am. J. Physiol., Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib33","doi-asserted-by":"crossref","first-page":"H1693","DOI":"10.1152\/ajpheart.00854.2012","article-title":"Insulin resistance protects the heart from fuel overload in dysregulated metabolic states","volume":"305","author":"Taegtmeyer","year":"2013","journal-title":"Am. J. Physiol., Heart Circ. Physiol."},{"key":"10.1016\/j.cmet.2026.06.012_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2337\/db14-0694","article-title":"Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes","volume":"64","author":"Nolan","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib36","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.2337\/db12-0108","article-title":"Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans","volume":"61","author":"Szendroedi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(24)00827-4","article-title":"Pathophysiology from preconception, during pregnancy, and beyond","volume":"404","author":"Hivert","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib38","first-page":"329","article-title":"Insulin level and insulin sensitivity indices among healthy children and adolescents","volume":"114","author":"Ballerini","year":"2016","journal-title":"Arch. Argent. Pediatr."},{"key":"10.1016\/j.cmet.2026.06.012_bib39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ijo.2017.4","article-title":"What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?","volume":"41","author":"Cuthbertson","year":"2017","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.cmet.2026.06.012_bib40","first-page":"E630","article-title":"Dose-response characteristics for effects of insulin on production and utilization of glucose in man","volume":"240","author":"Rizza","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cmet.2026.06.012_bib41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cmet.2026.06.012_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64985-9","article-title":"Multivariate genome-wide analyses of insulin resistance unravel novel loci and therapeutic targets for cardiometabolic health","volume":"16","author":"Ye","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2026.06.012_bib43","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s42255-024-01153-1","article-title":"Skeletal muscle from TBC1D4 p.Arg684Ter variant carriers is severely insulin resistant but exhibits normal metabolic responses during exercise","volume":"6","author":"Kristensen","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(24)00339-5","article-title":"Dissection of type 2 diabetes: a genetic perspective","volume":"13","author":"Bonnefond","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.012_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molmet.2019.03.004","article-title":"Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes","volume":"24","author":"Khamis","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.012_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","article-title":"Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance","volume":"3","author":"Bl\u00fcher","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cmet.2026.06.012_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1172\/JCI115274","article-title":"Insulin resistance associated with lower rates of weight gain in Pima Indians","volume":"88","author":"Swinburn","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2026.06.012_bib49","first-page":"85","article-title":"Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study","volume":"18","author":"Valdez","year":"1994","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.cmet.2026.06.012_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-17-0882","article-title":"Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study","volume":"178","author":"Honka","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.012_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cmet.2026.06.012_bib52","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jcem.87.8.8761","article-title":"Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans","volume":"87","author":"Virtanen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib53","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s00125-015-3676-7","article-title":"Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity","volume":"58","author":"Templeman","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-026-01240-1","article-title":"Hyperinsulinaemia as a cause of obesity and cardiometabolic diseases","author":"Guess","year":"2026","journal-title":"Nat. Rev. Endocrinol"},{"key":"10.1016\/j.cmet.2026.06.012_bib55","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/en.2009-1238","article-title":"Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832\/13 ss-cells","volume":"151","author":"El-Assaad","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2026.06.012_bib56","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies--new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.012_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1172\/JCI112389","article-title":"Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions","volume":"77","author":"Leahy","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cmet.2026.06.012_bib59","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.2337\/diabetes.50.2007.S154","article-title":"Beta-cell adaptation and decompensation during the progression of diabetes","volume":"50","author":"Weir","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib60","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.molmet.2017.04.010","article-title":"The dynamic plasticity of insulin production in beta-cells","volume":"6","author":"Boland","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib61","first-page":"365","article-title":"Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes","volume":"118","author":"Glaser","year":"1988","journal-title":"Acta Endocrinol.(Copenh)"},{"key":"10.1016\/j.cmet.2026.06.012_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1463-1326.1999.00015.x","article-title":"Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes","volume":"1","author":"Glaser","year":"1999","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib63","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib64","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/endo-129-4-2067","article-title":"Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose","volume":"129","author":"Kaiser","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2026.06.012_bib65","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/db21-1030","article-title":"Heterogeneous development of \u03b2-cell populations in diabetes-resistant and\u2014susceptible mice","volume":"71","author":"Gottmann","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cmet.2015.10.016","article-title":"Reduced insulin production relieves endoplasmic reticulum stress and induces beta cell proliferation","volume":"23","author":"Szabat","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib67","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib68","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: Pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.cmet.2026.06.012_bib69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-42-2-222","article-title":"Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests","volume":"42","author":"Brunzell","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2026.06.012_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199201023260104","article-title":"Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance","volume":"326","author":"Mitrakou","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib72","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diabetes.55.04.06.db05-1100","article-title":"The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study","volume":"55","author":"Festa","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib73","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(76)91473-2","article-title":"Improvement in insulin secretion in diabetes after diazoxide","volume":"1","author":"Greenwood","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib74","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1210\/jc.2018-00161","article-title":"Effects of diazoxide-mediated insulin suppression on glucose and lipid metabolism in nondiabetic obese men","volume":"103","author":"Loves","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib75","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/diabetes.52.10.2513","article-title":"NN414, a SUR1\/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat","volume":"52","author":"Carr","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib76","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/092986706775527947","article-title":"Towards selective Kir6.2\/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives","volume":"13","author":"Hansen","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cmet.2026.06.012_bib77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2007-973062","article-title":"The effects of NN414, a SUR1\/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes","volume":"115","author":"Zdravkovic","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib78","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1210\/jc.2018-01147","article-title":"High-dose, diazoxide-mediated insulin suppression boosts weight loss induced by lifestyle intervention","volume":"103","author":"Loves","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cmet.2026.06.012_bib80","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/diabetes.50.9.2105","article-title":"Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes","volume":"50","author":"Dyntar","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1113\/EP091566","article-title":"Myocardial steatosis across the spectrum of human health and disease","volume":"109","author":"Oneglia","year":"2024","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cmet.2026.06.012_bib82","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib83","doi-asserted-by":"crossref","first-page":"102016","DOI":"10.1016\/j.jacadv.2025.102016","article-title":"SGLT2 inhibitor treatment is associated with reduced cardiac glucose metabolism: a matched FDG-PET cohort study","volume":"4","author":"Sperry","year":"2025","journal-title":"JACC Adv."},{"key":"10.1016\/j.cmet.2026.06.012_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0026-0495(98)90264-5","article-title":"Effects of hyperglycemia and hyperinsulinemia on satiety in humans","volume":"47","author":"Gielkens","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.cmet.2026.06.012_bib85","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1139\/apnm-2014-0549","article-title":"Nutrients, satiety, and control of energy intake","volume":"40","author":"Tremblay","year":"2015","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/s12576-024-00904-9","article-title":"Satiety: a gut-brain-relationship","volume":"74","author":"Barakat","year":"2024","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.cmet.2026.06.012_bib87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tem.2015.06.005","article-title":"Brain glucose sensing in homeostatic and hedonic regulation","volume":"26","author":"Steinbusch","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib88","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cmet.2024.03.008","article-title":"Futile cycles: Emerging utility from apparent futility","volume":"36","author":"Sharma","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib89","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1152\/physrev.00024.2024","article-title":"Glycerolipid cycling in thermogenesis, energy homeostasis, signaling, and diseases","volume":"105","author":"Poursharifi","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cmet.2026.06.012_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-58294-4","article-title":"The futile creatine cycle powers UCP1-independent thermogenesis in classical BAT","volume":"16","author":"Bunk","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2026.06.012_bib91","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cmet.2015.09.007","article-title":"Brown and beige fat: physiological roles beyond heat generation","volume":"22","author":"Kajimura","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib92","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1210\/clinem\/dgae776","article-title":"Glycemic targets and prevention of complications","volume":"110","author":"Tsushima","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib93","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0031-9384(87)90072-2","article-title":"Hyperglycemia and fight-flight behavior in nondiabetic and diabetic mice","volume":"41","author":"Meehan","year":"1987","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cmet.2026.06.012_bib94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cmet.2026.06.012_bib95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: The SHINE Randomized Clinical Trial","volume":"322","author":"Johnston","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cmet.2026.06.012_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2396987317742065","article-title":"European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke","volume":"3","author":"Fuentes","year":"2018","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.cmet.2026.06.012_bib97","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/1673-5374.317959","article-title":"Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity","volume":"17","author":"Ferrari","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cmet.2026.06.012_bib98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2013.283980","article-title":"Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia","volume":"311","author":"Steele","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cmet.2026.06.012_bib99","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/dbi19-0014","article-title":"Nutrient-induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic beta-cell","volume":"69","author":"Prentki","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jn\/112.9.1756","article-title":"Role of exercise-training in the prevention of hyperinsulinemia caused by high energy diet","volume":"112","author":"Richard","year":"1982","journal-title":"J. Nutr."},{"key":"10.1016\/j.cmet.2026.06.012_bib101","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2026.06.012_bib102","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s11695-025-07858-w","article-title":"Effect of gastric bypass vs sleeve gastrectomy on remission of type 2 diabetes mellitus among patients with severe obesity: a meta-analysis","volume":"35","author":"Queiroz","year":"2025","journal-title":"Obes. Surg."},{"key":"10.1016\/j.cmet.2026.06.012_bib103","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/dom.15688","article-title":"The daunting task of recruiting insulin-treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions","volume":"26","author":"Sun","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib104","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.012_bib106","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib107","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1038\/s41586-020-2031-4","article-title":"Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.012_bib108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2007-979837","article-title":"Mechanisms of the glycaemic effects of sulfonylureas","volume":"28","author":"Ashcroft","year":"1996","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cmet.2026.06.012_bib109","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/jc.2004-0699","article-title":"Sulfonylurea induced beta-cell apoptosis in cultured human islets","volume":"90","author":"Maedler","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib110","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s00125-006-0433-y","article-title":"Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level","volume":"49","author":"Alarcon","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.012_bib111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.23067","article-title":"Cardiovascular events in individuals treated with sulfonylureas or dipeptidyl peptidase 4 inhibitors","volume":"8","author":"Turchin","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cmet.2026.06.012_bib112","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.23079","article-title":"Reassessing sulfonylurea safety in modern diabetes care","volume":"8","author":"Ratzki-Leewing","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cmet.2026.06.012_bib113","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI11705","article-title":"Unraveling the mechanism of action of thiazolidinediones","volume":"106","author":"Kahn","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2026.06.012_bib114","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/hep.32012","article-title":"Thiazolidinediones and glucagon-like peptide-1 receptor agonists and the risk of nonalcoholic fatty liver disease: a cohort study","volume":"74","author":"van Dalem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2026.06.012_bib115","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13675","article-title":"The effect of thiazolidinediones on body fat redistribution in adults: A systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Zhang","year":"2024","journal-title":"Obes. Rev."},{"key":"10.1016\/j.cmet.2026.06.012_bib116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164118825376","article-title":"Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes","volume":"16","author":"DeFronzo","year":"2019","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.cmet.2026.06.012_bib117","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.2337\/db12-0428","article-title":"Pioglitazone acutely reduces energy metabolism and insulin secretion in rats","volume":"62","author":"Lamontagne","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.012_bib118","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis","volume":"173","author":"Tsapas","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib119","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/dom.14988","volume":"25","author":"Nauck","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.012_bib121","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/dc13-2743","article-title":"Insulin therapy in people with type 2 diabetes: opportunities and challenges?","volume":"37","author":"Home","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2026.06.012_bib122","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cells14090668","article-title":"Expanding the use of SGLT2 inhibitors in T2D patients across clinical settings","volume":"14","author":"Cuttone","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cmet.2026.06.012_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/clinem\/dgad438","article-title":"Emergence of a new glucoregulatory mechanism for glycemic control with dapagliflozin\/exenatide therapy in type 2 diabetes","volume":"109","author":"Cersosimo","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13543784.2025.2472408","article-title":"The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines","volume":"34","author":"Madsbad","year":"2025","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cmet.2026.06.012_bib125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tem.2025.01.002","article-title":"Glucagon-like peptide-1 receptor agonism and end-organ protection","volume":"36","author":"Daniels","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.012_bib126","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fendo.2018.00649","article-title":"Future perspectives on GLP-1 receptor agonists and GLP-1\/glucagon receptor co-agonists in the treatment of NAFLD","volume":"9","author":"Seghieri","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2026.06.012_bib127","series-title":"The Normal and the Pathological","author":"Canguilhem","year":"1991"}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155041312600238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155041312600238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:06:24Z","timestamp":1791950784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155041312600238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S155041312600238X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2026.06.012","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2026.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}